Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans

• Status: Completed
• Trial end date: 2007-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effects of nebivolol on blood pressure and heart rate in African American patients with hypertension.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mylan Bertek Pharmaceuticals
• Treatments: Atenolol; Nebivolol

Criteria

Inclusion Criteria:

• African Americans with stage 1-2 hypertension

Exclusion Criteria:

• Recent myocardial infarction or stroke

• Contraindications to beta-blocker therapy or stopping prior antihypertensive therapy